Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.
Authors: Hure A; The University of Newcastle, Callaghan, New South Wales, Australia., Peel R; The University of Newcastle, Callaghan, New South Wales, Australia., D'Este C; The Sax Institute, Glebe, New South Wales, Australia., Abhayaratna WP; Canberra Hospital, Woden, Australian Capital Territory, Australia., Tonkin A; Monash University, Melbourne, Victoria, Australia., Hopper I; Monash University, Melbourne, Victoria, Australia., Thrift AG; School of Clinical Sciences at Monash Health, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia., Levi C; Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia., Sturm J; The University of Newcastle, Callaghan, New South Wales, Australia., Durrheim D; The University of Newcastle, Callaghan, New South Wales, Australia., Hung J; Medical School, University of Western Australia, Nedlands, Western Australia, Australia., Briffa T; School of Population Health, University of Western Australia, Perth, Western Australia, Australia., Chew DP; School of Medicine, Victorian Heart Hospital, Victorian Heart Institute, Bedford Park, South Australia, Australia., Ren S; The University of Newcastle, Callaghan, New South Wales, Australia., McEvoy M; The University of Newcastle, Callaghan, New South Wales, Australia., Hansbro P; Centenary Institute, Sydney, New South Wales, Australia., Newby D; School of Biomedical Science and Pharmacy, The University of Newcastle-Callaghan Campus, Callaghan, New South Wales, Australia., Szwec S; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Chiu S; College of Health, Medicine and Wellbeing, The University of Newcastle School of Medicine and Public Health, Callaghan, New South Wales, Australia., Attia J; Centre for Clinical Epidemiology and Biostatistics, The University of Newcastle-Callaghan Campus, Callaghan, New South Wales, Australia.
Source: JAMA cardiology [JAMA Cardiol] 2025 Nov 01; Vol. 10 (11), pp. 1112-1120.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2380-6591
DOI:10.1001/jamacardio.2025.3043